BP1HB
Bp Capital Markets P.L.C.
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
5.439% Snr Gtd Nts Mat 28-Aug-34 Min Cons $5Ht Nc
📈 Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in BP1HB
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in BP1HB
N/A
BP1HB investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in BP1HB also invest in...
Want more shares? Try these...
BPH Global Ltd. is a plant-based biotechnology company, which engages in the business of sourcing, producing, marketing, and selling traditional medicines. The company is headquartered in Melbourne, New South Wales. The company went IPO on 2000-06-13. The firm is focused on producing foods, health and cosmetic products which deliver Traditional Chinese Medicine (TCM)-based health outcomes. The company focuses on the research and development, production and commercialization of TCM products, including raw bird’s nest and processed bird’s nest products, raw seaweeds and sea plants as sustainable plant-based protein foods and nutraceutical and pharmaceutical ingredients extracted from seaweeds and sea plants for utilization in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. The Company’s product focus is on raw bird’s nests; higher-end processed bird’s nest products; and Sea Grapes (Caulerpa Lentillifera) and seaweeds. The firm's key markets are China, Singapore, Australia and Southeast Asia. Its subsidiaries include Hainan SCU Biotechnology Co Ltd, Foshan Gedishi Biotechnology Co Ltd, SCU Lab Pty Ltd, and others.
🙌 Performance (5Yr p.a)
-15.75%
📊 Share price
$0.00 AUD
🧬 BIOTECHNOLOGY
